Biomedical Textiles Market: Overview
The market size for biomedical textiles was USD 9852.5 million in 2021, and it is projected to grow at a CAGR of 5.7 percent during the forecast period. The demand for wound care products such as gauzes, plaster, and orthopedic implants will be a major driver accelerating the biomedical textiles market's growth rate. Another significant factor resulting in the market's growth is the senior population's expansion. Furthermore, the increasing number of surgeries and high-quality biomedical textiles are the major drivers that will expand the market's growth. Likewise, an increase in the number of chronic disorders and accidents and rapid urbanization will positively impact the market's growth rate. Increasing healthcare expenditure, changing lifestyles and a rise in disposable incomes in developing and developed countries will impact the growth rate of the biomedical textiles market.
Moreover, the increase in the development of smart biomedical textiles and advancement in medical technology will offer beneficial opportunities for the biomedical textiles market growth. Additionally, growing demand from emerging markets and rising awareness about health and hygiene will further expand the biomedical textiles market's growth during the forecast period. On the other hand, high R&D investment will hinder the market growth. Also, increasing pricing pressure on market players and product marketing will challenge the biomedical textiles market. However, the lack of healthcare professionals and less recognition will act as a restraint and further impede the market's growth rate.
The key players of the global biomedical textiles market adopt several strategies such as; partnerships, collaborations, and acquisitions to expand their global market reach. Players also make remarkable investments in R&D to add innovations to their products. For instance, in August 2021, TECNALIA announced its participation in developing printable and many biomedical electrodes. These are based on adaptable, smart fabric textiles. The company would manufacture electrodes with several elastic textile pads and integrated logic circuits, permitting flexible and adjustable placement. This initiative anticipates revolutionary advancements by integrating electronic devices with flexible biomedical electrodes based on wearable textile fibers. Furthermore, in July 2020, Secant Group announced that it had expanded biomaterial platform technology. It offers an implantable, resorbable polymer to fuel innovation in the pharma, medical device, and biopharma markets. The company aims to develop high-performance materials by combining traditional biomedical textiles with regenerative medicines to upgrade the quality of life. This initiative would assist innovative medical technology, and the newly introduced biomaterials are anticipated to be used in several additional areas, including novel implantable drug-delivery devices.
Biomedical Textiles Market: COVID-19 Impact
Medical device companies depend on healthcare facilities like pharmaceutical companies to gather clinical trial data. Most medical device products must experience pre and post-marketing clinical trials before manufacturers can obtain marketing approval certificates. As the COVID-19 pandemic unfolds, medical device companies struggle to make informed decisions about their supply chains, products, and regulatory obligations amid uncertainty. Medical device professionals have the unpleasant task of calling for a break in panic. Despite the adrenaline rush that tells us to manufacture as quickly as possible, this is when quality matters more than anything else.
Biomedical Textiles Market: Drivers
Growing Need for Advanced Wound Dressing Material to Drive Market Growth
Changing lifestyles, increasing disposable income, and growing awareness about health and hygiene have increased the demand for biomedical textiles with antibacterial, anti-fungal, and easy healing properties. According to a survey conducted by Dow Microbial Control, a business unit of The Dow Chemical Company (US), more than 60% of consumers demand advanced wound dressing materials to prevent dust, mold, and parasites bacterial, viral, and airborne infections. The survey also concluded that consumers purchase premium products to fulfill their requirements for wound dressing products with better performance.
Advancements in Healthcare Sector to Augment Market Growth
Due to growing healthcare budgets, increasing health awareness, and rising healthcare expenditure, the rising healthcare industry will likely drive the global biomedical textiles industry over the forecast period. Increasing cases of accidents, lifestyle diseases, and frequent infection spread propel the need for technological innovations to ease treatment processes, and thus, are anticipated to offer huge market scope for biomedical textile manufacturers in the healthcare industry. Furthermore, upcoming technology such as tissue engineering, wherein specially designed textiles can form a new tissue around them, which would allow the body not to depend solely on synthetic material for the implant, is expanding the popularity of biomedical textiles. The increasing geriatric population and the growing demand for wound care products such as; orthopedic implants and plaster casts are projected to expand the market growth in the forecast period. The surging chronic diseases, increasing road accidents, and the growing investment in the healthcare sector are other important factors bolstering the industry. Moreover, the ongoing development in technologies such as; tissue engineering is anticipated to further fuel the demand for biomedical textiles in the coming years.
Biomedical Textiles Market: Restraints
High R&D Investments to Hamper Market Growth
Biomedical textiles are advanced materials that resist several bacteria, fungi, fire, dirt, and water. Developing these fabrics involves extensive R&D to provide specialized products that meet healthcare specifications. The R&D costs involved in high-end manufacturing fabrics are high, including labor, technological, and other related costs. The production of raw materials, including polyester, cotton, polypropylene, polyurethane, vinyl, and other fibers, involves complex processes that require heavy investments. These materials also need efficient machinery, the latest technology, and adequate supply. Raw materials utilized in antimicrobial biomedical textiles include various fibers and antimicrobial agents such as silver, copper, and quaternary ammonium, which are highly expensive. Moreover, players in the market must monitor the production of high-quality textiles as it is a complex process. Thus, the R&D investments needed in manufacturing these textiles are high, thereby hampering the market's growth.
Biomedical Textiles Market: Segment Overview
Increasing Surgeries to Grow Non-Implantable Biomedical Textiles Segment
The non-implantable biomedical textiles segment will dominate the global biomedical textile share during the forecast period. The expansion can be attributed to the increase in demand for non-implantable applications such as; tubular, gauze, adhesive, cohesive, and triangular bandages. The segment provides characteristics such as; softness, absorption, fit, absorption, and cost-effectiveness, which is anticipated to expand its demand in the forecast period. Furthermore, the increased number of accidents and surgeries is predicted to grow the demand for non-implantable textiles, fueling the market during the forecast period.
Increasing Applications of Non-Biodegradable Fibers in Soft & Hard Tissue Implants Drives Market Growth
The non-biodegradable fiber type segment is attributed to the largest growth and is also anticipated to grow at the highest CAGR during the forecast period. Non-biodegradable fibers are slowly soaked up by the body and take more than six months to break down. The segment of the non-biodegradable fiber type is due to the high consumption of non-biodegradable fibers, including polypropylene, polyethylene, viscose, polyamide, and polyester in several applications as surgical sutures, bandages, hard and soft tissue implants, and extracorporeal devices.
Biomedical Textiles Market: Regional Landscape
Growing Obese to Boost Biomedical Fabric Demand in North America
North America is expected to lead the global market due to key players and highly evolved healthcare centers. The increasing incidences of obesity are projected to expand the demand for biomedical textiles in several applications, thereby bolstering the market. As per the National Institutes of Health data, 10-15% of the US population suffers from gallstones in the bile duct, and nearly 5 million Americans suffer from valve-related heart diseases. The cure of such diseases demands advanced medical devices, including biomedical textiles. In addition, the high expenditures of the U.S to improve their healthcare sector is likely to fuel and present lucrative market opportunities for expansion during the forecast period.
The Asia-Pacific region is anticipated to be the fastest-growing market for biomedical textiles during the forecast period. Emerging markets are attributed in the APAC region, such as China, India, and Singapore, with increased health spending and the growth in disposable income driving the expansion of the biomedical textiles market in the region. Furthermore, the increasing expenditure for establishing technical textile factories will directly stimulate the call for the biomedical textiles market. For example, the Gujarat (India) state government intends to create a textile technical mission to attract an investment of $ 1.62 billion to establish 2,000 textile technical manufacturing facilities. Therefore, the growth in the call for technical textiles will directly influence the call for biomedical textiles in the region. Asia-Pacific is anticipated to be a very attractive market. Furthermore, the increasing number of healthcare centers to facilitate quality services is fueling the market's demand in the Asia Pacific.
Global Biomedical Textiles Market: Competitive Landscape
In January 2022, Confluent Medical Technologies, a renowned name in offering biomedical textile services, announced that TPG Capital would majorly invest in the company. Moreover, in January 2022, the Johnson & Johnson Medical Devices Companies (JJMDC) announced that it would collaborate with Microsoft to enable and increase JJMDC's compliant digital surgery ecosystem. Additionally, in January 2018, Medtronic plc launched the new SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that offers targeted drug delivery for chronic pain and severe spasticity. The SynchroMed II pump provides medication directly to the fluid around the spinal cord.
Few of the players in the Biomedical Textiles Market include Paul Hartmann (Germany), BSN Medical (Sweden), Royal DSM (Netherlands), Covidien (Ireland), Integra Life Sciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B. Braun Melsungen (Germany), and Cardinal Health (US).
Regional Classification of the Global Biomedical Textiles Market is Listed Below:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
*Regions and countries are subject to change based on data availability.
Key Elements Included In The Study: Global Biomedical Textiles Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
1. Executive Summary
1.1. Global Biomedical Textiles Market: Snapshot
1.2. Future Projections, 2023 - 2030, (US$ Mn)
1.3. Key Segment Analysis and Competitive Insights
1.4. Premium Insights
2. Market Overview
2.1. Market Definitions and Segmentation
2.2. Market Dynamics
2.2.1. Driver
2.2.2. Restraint
2.2.3. Industry Challenges & Opportunities
2.3. Market Forces Analysis
2.3.1. Value Chain Analysis
2.3.2. Porters Five Forces Analysis
2.4. Challenges and Solutions
2.5. Supply Chain Impact Analysis
2.6. COVID-19 Impact Analysis
2.6.1. Pre and Post Covid-19 Analysis
2.7. Regulatory Scenario
2.8. Economic Analysis
3. Global Biomedical Textiles Market Outlook, 2019 - 2030
3.1. Global Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
3.1.1. Key Highlights
3.1.1.1. Woven
3.1.1.2. Non-Woven
3.1.1.3. Other
3.2. Global Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
3.2.1. Key Highlights
3.2.1.1. Biodegradable
3.2.1.2. Non-Biodegradable
3.3. Global Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
3.3.1. Key Highlights
3.3.1.1. General Surgery
3.3.1.2. Cardiology
3.3.1.3. Orthopedics
3.3.1.4. Cosmetics
3.3.1.5. Dental
3.3.1.6. Tissue Engineering
3.3.1.7. Other
3.4. Global Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
3.4.1. Key Highlights
3.4.1.1. Implantable Material
3.4.1.2. Non-Implantable Material
3.4.1.3. Extracorporeal Implant
3.4.1.4. Other
3.5. Global Biomedical Textiles Market Outlook, by Region, Value (US$ Mn), 2019 - 2030
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
3.5.2. Market Attractiveness Analysis
4. North America Biomedical Textiles Market Outlook, 2019 - 2030
4.1. North America Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
4.1.1. Key Highlights
4.1.1.1. Woven
4.1.1.2. Non-Woven
4.1.1.3. Other
4.2. North America Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
4.2.1. Key Highlights
4.2.1.1. Biodegradable
4.2.1.2. Non-Biodegradable
4.3. North America Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
4.3.1. Key Highlights
4.3.1.1. General Surgery
4.3.1.2. Cardiology
4.3.1.3. Orthopedics
4.3.1.4. Cosmetics
4.3.1.5. Dental
4.3.1.6. Tissue Engineering
4.3.1.7. Other
4.4. North America Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
4.4.1. Key Highlights
4.4.1.1. Implantable Material
4.4.1.2. Non-Implantable Material
4.4.1.3. Extracorporeal Implant
4.4.1.4. Other
4.5. North America Biomedical Textiles Market Outlook, by Country, Value (US$ Mn), 2019 - 2030
4.5.1. Key Highlights
4.5.1.1. U.S.
4.5.1.2. Canada
5. Europe Biomedical Textiles Market Outlook, 2019 - 2030
5.1. Europe Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
5.1.1. Key Highlights
5.1.1.1. Woven
5.1.1.2. Non-Woven
5.1.1.3. Other
5.2. Europe Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
5.2.1. Key Highlights
5.2.1.1. Biodegradable
5.2.1.2. Non-Biodegradable
5.3. Europe Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
5.3.1. Key Highlights
5.3.1.1. General Surgery
5.3.1.2. Cardiology
5.3.1.3. Orthopedics
5.3.1.4. Cosmetics
5.3.1.5. Dental
5.3.1.6. Tissue Engineering
5.3.1.7. Other
5.4. Europe Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
5.4.1. Key Highlights
5.4.1.1. Implantable Material
5.4.1.2. Non-Implantable Material
5.4.1.3. Extracorporeal Implant
5.4.1.4. Other
5.5. Europe Biomedical Textiles Market Outlook, by Country, Value (US$ Mn), 2019 - 2030
5.5.1. Key Highlights
5.5.1.1. Germany
5.5.1.2. France
5.5.1.3. U.K.
5.5.1.4. Italy
5.5.1.5. Rest of Europe
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biomedical Textiles Market Outlook, 2019 - 2030
6.1. Asia Pacific Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
6.1.1. Key Highlights
6.1.1.1. Woven
6.1.1.2. Non-Woven
6.1.1.3. Other
6.2. Asia Pacific Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
6.2.1. Key Highlights
6.2.1.1. Biodegradable
6.2.1.2. Non-Biodegradable
6.3. Asia Pacific Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
6.3.1. Key Highlights
6.3.1.1. General Surgery
6.3.1.2. Cardiology
6.3.1.3. Orthopedics
6.3.1.4. Cosmetics
6.3.1.5. Dental
6.3.1.6. Tissue Engineering
6.3.1.7. Other
6.4. Asia Pacific Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
6.4.1. Key Highlights
6.4.1.1. Implantable Material
6.4.1.2. Non-Implantable Material
6.4.1.3. Extracorporeal Implant
6.4.1.4. Other
6.5. Asia Pacific Biomedical Textiles Market Outlook, by Country, Value (US$ Mn), 2019 - 2030
6.5.1. Key Highlights
6.5.1.1. China
6.5.1.2. Japan
6.5.1.3. South Korea
6.5.1.4. India
6.5.1.5. Rest of Asia Pacific
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biomedical Textiles Market Outlook, 2019 - 2030
7.1. Latin America Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
7.1.1. Key Highlights
7.1.1.1. Woven
7.1.1.2. Non-Woven
7.1.1.3. Other
7.2. Latin America Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
7.2.1. Key Highlights
7.2.1.1. Biodegradable
7.2.1.2. Non-Biodegradable
7.3. Latin America Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
7.3.1. Key Highlights
7.3.1.1. General Surgery
7.3.1.2. Cardiology
7.3.1.3. Orthopedics
7.3.1.4. Cosmetics
7.3.1.5. Dental
7.3.1.6. Tissue Engineering
7.3.1.7. Other
7.4. Latin America Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
7.4.1. Key Highlights
7.4.1.1. Implantable Material
7.4.1.2. Non-Implantable Material
7.4.1.3. Extracorporeal Implant
7.4.1.4. Other
7.5. Latin America Biomedical Textiles Market Outlook, by Country, Value (US$ Mn), 2019 - 2030
7.5.1. Key Highlights
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biomedical Textiles Market Outlook, 2019 - 2030
8.1. Middle east & Africa Biomedical Textiles Market Outlook, by Fabric Type, Value (US$ Mn), 2019 - 2030
8.1.1. Key Highlights
8.1.1.1. Woven
8.1.1.2. Non-Woven
8.1.1.3. Other
8.2. Middle East & Africa Biomedical Textiles Market Outlook, by Fiber, Value (US$ Mn), 2019 - 2030
8.2.1. Key Highlights
8.2.1.1. Biodegradable
8.2.1.2. Non-Biodegradable
8.3. Middle East & Africa Biomedical Textiles Market Outlook, by Product Application, Value (US$ Mn), 2019 - 2030
8.3.1. Key Highlights
8.3.1.1. General Surgery
8.3.1.2. Cardiology
8.3.1.3. Orthopedics
8.3.1.4. Cosmetics
8.3.1.5. Dental
8.3.1.6. Tissue Engineering
8.3.1.7. Other
8.4. Middle East & Africa Biomedical Textiles Market Outlook, by Category, Value (US$ Mn), 2019 - 2030
8.4.1. Key Highlights
8.4.1.1. Implantable Material
8.4.1.2. Non-Implantable Material
8.4.1.3. Extracorporeal Implant
8.4.1.4. Other
8.5. Middle East & Africa Biomedical Textiles Market Outlook, by Country, Value (US$ Mn), 2019 - 2030
8.5.1. Key Highlights
8.5.1.1. GCC
8.5.1.2. South Africa
8.5.1.3. Rest of Middle East & Africa
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Market Share Analysis, 2021
9.2. Competition Matrix (By Tier and Size of companies)
9.3. Strategic Collaborations
9.3.1. Joint Ventures
9.3.2. Mergers & Acquisitions
9.4. Company Profiles
9.4.1. Congluent Medical Technologies, Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
(*Note: Above details would be available for the below list of companies based on availability)
9.4.2. Atex Technologies, Inc.
9.4.3. Secant Medical, LLC
9.4.4. Swicofil AG
9.4.5. Bally Ribbon Mills (BRM)
9.4.6. Hartmann USA, Inc.
9.4.7. Medline Industries, LP
9.4.8. Proxy Biomedical Limited
9.4.9. US BioDesign, Inc.
9.4.10. Other
10. Appendix
10.1. Acronyms and Abbreviations
10.2. Research Scope & Assumptions
10.3. Research Methodology and Information Sources
BASE YEAR |
HISTORICAL DATA |
FORECAST PERIOD |
UNITS |
|||
2022 |
2019 - 2022 |
2023 - 2030 |
Value: US$ Million |
REPORT FEATURES |
DETAILS |
Fabric Type Coverage |
|
Fiber Coverage |
|
Category Coverage |
|
Product Application Coverage |
|
Geographical Coverage |
|
Leading Market Companies |
|
Report Highlights |
Market Estimates and Forecast, Market Dynamics, Industry Trends, Competition Landscape, Fabric, Fiber-, Product-, Category-, Region-, Country-wise Trends & Analysis, COVID-19 Impact Analysis (Demand and Supply), Key Market Trends |
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology